Ayala Pharmaceuticals Inc (ADXS)

[northern vortex]

Contrary to some opinions expressed on this board, I like the way the BOD are being tight-lipped regarding the path forward for the company after the DOC resignation. IMHO, Vague is Good. Look at what an open-book policy including the identification of various timelines during Investor Day did for the stock price. As soon as the shorts & MM sensed that there was little risk of a catalyst to energize the stock price, they savaged it. IMHO, it was the straw that broke the camel’s back regarding DOC’s tenure.

Rather than articulating the path forward, I suggest that an immediate priority of the CEO should be to rein in spending and raise more cash when appropriate; in whatever non dilutive way he can, before the company is in definite need of that cash. Otherwise, any sense of desperation on this front will likely send the stock price much lower in 2018, possibly during a period of risk-off trading for biotech stocks. Thru it all, the science will take care of itself.